Conférences - Pharmacologie et développement des médicaments - Allemagne

Sélecionner un pays
1
3rd International Symposium FRONTIERS IN BIOMATERIAL SCIENCE
20 mar 2020 - 21 mar 2020 • Leipzig, Allemagne
Organisateur:
Leipzig University, Faculty of Medizin & Leipzig University Medical Center
Résumé:
The symposium focuses on the following TOPICS: Biomaterials, Bone, Wound healing, Interleukin-17, Highlights of Transregio 67. We are very happy to announce the participation of internationally acclaimed keynote speakers who will cover these topics. In addition, we will present the most interesting projects from our collaborative research center.
Sujets:
Biomaterials, Bone, Wound healing, skin, Interleukin-17, TRR67, Biochemie
Identifiant de l'évènement:
1324932
Sujets apparentés:
2
ITOC7 — 7th Immunotherapy of Cancer Conference
02 avr 2020 - 04 avr 2020 • Munich, Allemagne
Organisateur:
ITOC7 is organised by the WMA GmbH in scientific cooperation with the ITOC Association, the Tumor Centre in Munich (TZM), the Society for Immunotherapy of Cancer (SITC), the German Cancer Consortium (DKTK) as well as the Comprehensive Cancer Center Munic
Résumé:
The 7th Immunotherapy of Cancer Conference (ITOC7) to be held in Munich, Germany from April 2 – 4, 2020 is a European meeting providing a global platform for translational research in the field of immuno-oncology as well as a forum for discussion of early clinical translation and to address its unique challenges. The main goal of the series of ITOC conferences is to provide a unique platform for discussions where all those dedicated to the immunotherapy of cancer can exchange their knowledge and latest findings to advance the oncology drug development and delivery.
Contact:
WMA GmbH Congress Office;     Tél.: [+431405138318];     Email.: itoc@medacad.org
Sujets:
Emerging concepts / novel agents Microbiome and immune system/immunotherapy Tumor microenvironment Vaccine Therapy Precision Medicine Meets Immunotherapy (Immuno-Monitoring) Cell Therapy in Solid Tumors Cell Therapy in Haematologic Diseases Combination Therapy
Identifiant de l'évènement:
1300563
Sujets apparentés:
3
ECI — Pharmaceutical Engineering: At the Frontier of Drug Substance and Drug Product
03 mai 2020 - 07 mai 2020 • Irsee, Allemagne
Organisateur:
Engineering Conferences International (ECI)
Résumé:
It is well known that the physical and chemical properties of the DS (API) have major impacts on the formulation and the Drug Product (DP) process. In any dosage form including solid, liquid and semi-solid, the Drug Substance (DS) or Active Pharmaceutical Ingredient (API) goes through a formulation process. This process to make the final drug product serves many purposes, but all with the goal of eventually delivering the active ingredient to the desired sites in the patients’ body in the most convenient way and to achieve optimal therapeutic effect.
Contact:
Tél.: [2125146760];     Email.: noel@engconfintl.org
Sujets:
Role particle engineering process scaleup Pharmaceutical composite materials DS/DP interface integration DS (API)
Identifiant de l'évènement:
1217753
4
DDSEU 2020 — 21st Annual Drug Discovery and 8th Annual Drug Design & Medicinal Chemistry Congress
26 mai 2020 - 27 mai 2020 • Berlin, Allemagne
Organisateur:
Oxford Global
Résumé:
The events are aimed at VPs and senior directors of discovery in biology and chemistry from global pharmaceutical and biotech organisations. New for 2020, the event features focused R&D leaders sessions on Drug discovery Modalities and AI in drug development. It will also highlights successful strategies in delivering On Target Discovery, Phenotypic/Crispr Screening, Applications Of Organ-In-A Chip Platforms As Well As Tissue And 3D Culture For Disease Modelling. Empowering Drug Discovery with Chemical Biology, senior experts will also learn about enabling technologies that facilitate quicker drug development timelines such as protein degradation tools, target-based discovery techniques including RNA as novel targets. Do not miss out on cutting edge insights into computational chemistry and drug design methods.
Contact:
Tél.: [+441865248455];     Email.: g.alonso@oxfordglobal.co.uk
Sujets:
Drug Discovery, Drug Design, Medicinal Chemistry
Identifiant de l'évènement:
1301531
5
NEURO2020 — 2nd Annual Neuroscience Drug Discovery Congress
26 mai 2020 - 27 mai 2020 • Berlin, Allemagne
Organisateur:
Oxford Global
Résumé:
Oxford Global is proud to present our 2nd Annual Neuroscience Drug Discovery Congress, taking place 26 – 27 May 2020 in Berlin, Germany, which will bring together key leaders and influencers from global pharmaceutical organisations and leading academic research institutions. Discover the latest developments and critical approaches in neuroscience discovery, alongside cutting-edge enabling tools and technologies for developing neurological treatments. The congress encompasses the emerging trends and technological breakthroughs in drug discovery for neurodegenerative diseases, together with presentations on advancements in stem cell technologies to fuel drug discovery and iPS cells in disease modelling. On Day 2, we aim to emphasise the importance of targeted therapeutics and the crucial roles of biomarker development and gene therapy in drug discovery and translational neuroscience.

Key speakers include:

• Emilio Merlo Pich, Executive Director Neurology & Quantitative Medicine Neuroscience Therapeutic Area, Takeda

• Andreas Hartmann, Executive Director PreClinical Safety, Therapeutic Area Head, Novartis

• Ross Jeggo, Head of Research, Neuropsychiatry Centre for Therapeutic Innovation, Servier

View the Agenda: https://bit.ly/2rYH2kT

With over 20 unmissable presentations, the two-day congress offers an intuitive platform for high level scientific and business discussions, ensuring valuable networking and interactive sessions.

This events form part of the R&D Series EU and are co-located with our 21st Annual Drug Discovery Summit and 8th Annual Drug Design & Medicinal Chemistry Congress

For more information contact g.alonso@oxfordglobal.co.uk or visit the website: https://bit.ly/2PfND2z

Go Social: Join our Drug Discovery & Development Network on LinkedIn, follow us on Twitter @drugdiscovery1 and & join the conversation at #RNDSeries20

LIVE WEBINAR:

Predictive Model Approaches For Pharmacokinetics And Pharmacodynamics In CNS Discovery

Hosted by Elizabeth de Lange, Professor in Predictive Pharmacology, LACDR, Leiden University

Register (free): https://bit.ly/2RQHjBg

Contact:
Tél.: [+441865248455];     Email.: g.alonso@oxfordglobal.co.uk
Sujets:
Neuroscience, Drug Discovery, Drug Development, Drug Design, Medicinal Chemistry
Identifiant de l'évènement:
1307055
Sujets apparentés:


Conference-Service.com met à la disposition de ses visiteurs des listes de conférences et réunions dans le domaine scientifique. Ces listes sont publiées pour le bénéfice des personnes qui cherchent une conférence, mais aussi, bien sûr, pour celui des organisateurs. Noter que, malgré tout le soin que nous apportons à la vérification des données entrées dans nos listes, nous ne pouvons accepter de responsabilité en ce qui concerne leur exactitude ou étendue. Pensez donc à vérifier les informations présentées avec les organisateurs de la conférence ou de la réunion avant de vous engager à y participer!

Dernière mise à jour: 30 Janvier 2020